U.S. Medical Eligibility Criteria for Contraceptive Use, 2024
The "U.S. Medical Eligibility Criteria for Contraceptive Use, 2024" is a deleted CDC publication, presented here in its unchanged original form. This document, published in the Morbidity and Mortality Weekly Report (MMWR) by the Centers for Disease Control and Prevention (CDC), provides evidence-based recommendations for healthcare providers on the safe use of contraceptive methods for individuals with various medical conditions and characteristics.
Key Features of the Document:
Updated Guidelines: Replaces the 2016 U.S. Medical Eligibility Criteria, incorporating the latest scientific research and expert recommendations.
Expanded Medical Considerations: Includes new recommendations for individuals with conditions such as chronic kidney disease, systemic lupus erythematosus, thrombophilia, and peripartum cardiomyopathy.
Comprehensive Contraceptive Classifications: Provides guidance on the safety of:
Intrauterine devices (IUDs)
Hormonal contraceptives (pills, patches, rings, injections, implants)
Barrier methods (male/female condoms, diaphragms, cervical caps)
Fertility awareness-based methods
Emergency contraception (morning-after pills and IUDs)
Equity and Patient Autonomy Focus: Emphasizes non-coercive, patient-centered counseling, recognizing historical injustices in reproductive healthcare and the importance of shared decision-making.
Clinical Application: Designed to assist healthcare providers, reproductive health specialists, and public health professionals in making individualized, evidence-based contraceptive decisions while minimizing unnecessary medical barriers.
Disclosure:
This document is presented in its unaltered form as originally published by the CDC before its removal.
The "U.S. Medical Eligibility Criteria for Contraceptive Use, 2024" is a deleted CDC publication, presented here in its unchanged original form. This document, published in the Morbidity and Mortality Weekly Report (MMWR) by the Centers for Disease Control and Prevention (CDC), provides evidence-based recommendations for healthcare providers on the safe use of contraceptive methods for individuals with various medical conditions and characteristics.
Key Features of the Document:
Updated Guidelines: Replaces the 2016 U.S. Medical Eligibility Criteria, incorporating the latest scientific research and expert recommendations.
Expanded Medical Considerations: Includes new recommendations for individuals with conditions such as chronic kidney disease, systemic lupus erythematosus, thrombophilia, and peripartum cardiomyopathy.
Comprehensive Contraceptive Classifications: Provides guidance on the safety of:
Intrauterine devices (IUDs)
Hormonal contraceptives (pills, patches, rings, injections, implants)
Barrier methods (male/female condoms, diaphragms, cervical caps)
Fertility awareness-based methods
Emergency contraception (morning-after pills and IUDs)
Equity and Patient Autonomy Focus: Emphasizes non-coercive, patient-centered counseling, recognizing historical injustices in reproductive healthcare and the importance of shared decision-making.
Clinical Application: Designed to assist healthcare providers, reproductive health specialists, and public health professionals in making individualized, evidence-based contraceptive decisions while minimizing unnecessary medical barriers.
Disclosure:
This document is presented in its unaltered form as originally published by the CDC before its removal.
The "U.S. Medical Eligibility Criteria for Contraceptive Use, 2024" is a deleted CDC publication, presented here in its unchanged original form. This document, published in the Morbidity and Mortality Weekly Report (MMWR) by the Centers for Disease Control and Prevention (CDC), provides evidence-based recommendations for healthcare providers on the safe use of contraceptive methods for individuals with various medical conditions and characteristics.
Key Features of the Document:
Updated Guidelines: Replaces the 2016 U.S. Medical Eligibility Criteria, incorporating the latest scientific research and expert recommendations.
Expanded Medical Considerations: Includes new recommendations for individuals with conditions such as chronic kidney disease, systemic lupus erythematosus, thrombophilia, and peripartum cardiomyopathy.
Comprehensive Contraceptive Classifications: Provides guidance on the safety of:
Intrauterine devices (IUDs)
Hormonal contraceptives (pills, patches, rings, injections, implants)
Barrier methods (male/female condoms, diaphragms, cervical caps)
Fertility awareness-based methods
Emergency contraception (morning-after pills and IUDs)
Equity and Patient Autonomy Focus: Emphasizes non-coercive, patient-centered counseling, recognizing historical injustices in reproductive healthcare and the importance of shared decision-making.
Clinical Application: Designed to assist healthcare providers, reproductive health specialists, and public health professionals in making individualized, evidence-based contraceptive decisions while minimizing unnecessary medical barriers.
Disclosure:
This document is presented in its unaltered form as originally published by the CDC before its removal.